Literature DB >> 28711089

Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3).

Andrew Blauvelt1, Kim A Papp2, Mark G Lebwohl3, Lawrence J Green4, Sylvia Hsu5, Varsha Bhatt6, Shipra Rastogi7, Radhakrishnan Pillai6, Robert Israel7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28711089     DOI： 10.1016/j.jaad.2017.03.026

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  11 in total

Review 1.  The Use of Brodalumab in Three Patients with Psoriasis and Psychiatric Comorbidities.

Authors:  Ryan Rivera-Oyola; Roselyn Stanger; Graham H Litchman; Quinn Thibodeaux; John Koo; Richard Fried; Gary Goldenberg; George Han; Sylvia Hsu; Leon Kircik; Melissa Knuckles; Andrea Murina; Jeffrey Weinberg; Jashin J Wu; Mark Lebwohl
Journal:  J Clin Aesthet Dermatol       Date:  2020-12-01

Review 2.  Brodalumab: A Review in Moderate to Severe Plaque Psoriasis.

Authors:  Hannah A Blair
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

Review 3.  Cytokines in uveitis.

Authors:  Jessica E Weinstein; Kathryn L Pepple
Journal:  Curr Opin Ophthalmol       Date:  2018-05       Impact factor: 3.761

Review 4.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2022-05-23

Review 5.  Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis.

Authors:  Kathryn L Pepple; Phoebe Lin
Journal:  Ophthalmology       Date:  2018-07-04       Impact factor: 12.079

6.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2021-04-19

7.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Sivem Afach; Liz Doney; Corinna Dressler; Camille Hua; Canelle Mazaud; Céline Phan; Carolyn Hughes; Dru Riddle; Luigi Naldi; Ignacio Garcia-Doval; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2020-01-09

Review 8.  Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date.

Authors:  Kristen M Beck; Isabelle M Sanchez; Eric J Yang; Wilson Liao
Journal:  Psoriasis (Auckl)       Date:  2018-08-29

9.  A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate-to-severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO-BIO-REAL).

Authors:  J Seneschal; J-P Lacour; A Bewley; M Faurby; C Paul; G Pellacani; C De Simone; L Horne; A Sohrt; M Augustin; E Hammond; K Reich
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-08       Impact factor: 6.166

10.  Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL).

Authors:  Jean-Philippe Lacour; Anthony Bewley; Edward Hammond; Jes B Hansen; Laura Horne; Carle Paul; Kristian Reich; Julien Seneschal; Clara De Simone; Anne Sohrt; Matthias Augustin; Giovanni Pellacani
Journal:  Dermatol Ther (Heidelb)       Date:  2020-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.